ArticleMagnesium as a Calcification Inhibitor
Key Words
Chronic kidney disease
Magnesium
Vascular calcification
Cited by (0)
Financial Disclosure: Z.A.M. reports grants for CKD REIN and other research projects from Amgen, Baxter, Fresenius Medical Care, GlaxoSmithKline, Merck Sharp and Dohme-Chibret, Sanofi-Genzyme, Lilly, Otsuka, and the French government as well as personal fees and grants to charities from Amgen, Bayer, and Sanofi-Genzyme. These sources of funding are not necessarily related to the content of the present manuscript. Also see Acknowledgment(s) on page 288.
© 2017 by the National Kidney Foundation, Inc. All rights reserved.